Publications
5600 Results
- Journal / Conference
- British Journal of Haematology Nov;171(4):530-538
- Year
- 2015
- Research Committee(s)
- Lymphoma
- PMID
- PMID26343802
- PMC
- PMC4881845
- Study Number(s)
- E2496
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era
- Journal / Conference
- Journal of Clinical Oncology 33 (suppl 7; abstr 152);ASCO GU Cancers Sympos (February 26-28, 2015, Orlando, FL), poster;
- Year
- 2015
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1014
Phase II trial of abiraterone acetate (AA) treatment for metastatic prostate cancer (PC) patients with a PSA of more than four following initial androgen deprivation therapy: SWOG S1014
- Journal / Conference
- Prostate Cancer and Prostatic Diseases, Sep;18(3):264-269
- Year
- 2015
- Research Committee(s)
- Cancer Control
- PMID
- PMID25939516
- PMC
- PMC4537352
- Study Number(s)
- SWOG-9217
Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng/mL, normal DRE, and negative for prostate cancer
- Journal / Conference
- Cancer, Jul 1;121(13):2193-2197
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID25827820
- PMC
- PMC4589423
- Study Number(s)
- S1005
A phase II study of MK-2206, an allosteric inhibitor of AKT as second line therapy for advanced gastric and gastroesophageal junction cancer, a SWOG cooperative group trial (S1005)
- Journal / Conference
- Journal of Clinical Oncology 33 (suppl 7; abstr 403); ASCO GU Cancers Symposium (February 26-28, 2015, Orlando, FL), general poster session;
- Year
- 2015
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/E2805
Results from ASSURE (E2805): adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase 3 trial
- Journal / Conference
- Experimental Biology 2015 Conference (March 28-April 1, 2015, Boston, MA), oral presentation, abst. #406.2;
- Year
- 2015
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Serum carotenoid concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Clinical Oncology Jun 10;33(17):1910-1917
- Year
- 2015
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID25940724
- PMC
- PMC4451174
- Study Number(s)
- S0927
Randomized multicenter placebo-controlled trial of omega-3-fatty acid for the control of aromatase inhibitor-induced musculoskeletal pain (S0927)
- Journal / Conference
- Cancer Prevention Research Jul;8(7):590-596
- Year
- 2015
- Research Committee(s)
- Cancer Control
- PMID
- PMID25926387
- PMC
- PMC4491033
- Study Number(s)
- SWOG-9217
Association between serum fatty acids and intraprostatic inflammation in the placebo arm of the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Urology, Vol. 193, Issue 4, e807 [abst MP65-02]; American Urological Association (May 15-19, 2015, New Orleans), moderated poster presentation;
- Year
- 2015
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1011
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer: SWOG S1011 (NCT #01224665)
- Journal / Conference
- PLOS ONE Jun 30; 10(6):e0131106
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID26125186
- PMC
- PMC4488332
- Study Number(s)
- S0000